Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4
Drug Metabolism and Disposition · 2023
DOI: 10.1124/dmd.123.001382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Luc R A Rougée und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lilly Research Laboratories; Eli Lilly and Company, Indianapolis, Indiana lrougee@lilly.com. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Midazolam. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lilly Research Laboratories; Eli Lilly and Company, Indianapolis, Indiana lrougee@lilly.com.
- Lilly Research Laboratories; Eli Lilly and Company, Indianapolis, Indiana.
Zitieren
APA
Rougée, L. R. A., Bedwell, D. W., Hansen, K., Abraham, T. L., & Hall, S. D. (2023). Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001382
Vancouver
Rougée LRA, Bedwell DW, Hansen K, Abraham TL, Hall SD. Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001382
BibTeX
@article{Rouge2023,
author = {Rougée, Luc R A and Bedwell, David W and Hansen, Kasi and Abraham, Trent L and Hall, Stephen D},
title = {Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4},
journal = {Drug Metabolism and Disposition},
year = {2023},
doi = {10.1124/dmd.123.001382}
}
EUVIMED